Title : Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Treatment in Type 1 Diabetes in a Tertiary Care Center in Saudi Arabia.

Pub. Date : 2022 Jan

PMID : 35586391






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Background Adjunctive treatment with sodium-glucose co-transporters 2 inhibitors (SGLT2- I) has been successfully used in patients with type 1 diabetes mellitus (T1DM) in recent years to improve glycemic control and reduce body weight without increasing the risk of hypoglycemia; however, there is a scarcity of evidence for real-world experience in their use in T1DM Saudi patients. Glucose solute carrier family 5 member 2 Homo sapiens